🔬 Research Use Only • 99%+ High-Purity Research Peptides • Third-Party Tested • Certificate of Analysis (COA) Available • Fast Worldwide Shipping • Bulk Orders Welcome • Secure Checkout • Trusted by Research Laboratories • Not Intended for Human Consumption or Clinical Use

CJC-1295 + Ipamorelin Blend

CJC-1295 + Ipamorelin Blend is a premium research-grade peptide combination formulated for laboratory investigations involving growth hormone-releasing hormone (GHRH) receptor signaling and ghrelin receptor (GHSR-1a) activation. This high-purity lyophilized blend combines the prolonged receptor engagement of CJC-1295 with the selective receptor activity of Ipamorelin, providing researchers with a valuable experimental model for studying endocrine signaling, growth hormone pulse dynamics, IGF-1 regulatory pathways, and neuroendocrine communication. Every batch is independently verified and supplied with a Certificate of Analysis (COA).

For research use only. Not intended for human consumption or clinical use.

Buy CJC-1295 + Ipamorelin Blend | High-Purity

🧬
Research Grade

Premium Laboratory Quality

📄
COA Included

Batch-Specific Documentation

🧪
Third-Party Tested

Identity & Purity Verified

🚚
Fast Shipping

Worldwide Delivery

This product is currently out of stock and unavailable.

📦
Discreet Packaging 100% Private
🛡️
Secure Shipping Fast & Reliable
Free Delivery On Crypto Payments
🚚
Expedited Shipping Delivery in 2–3 Days

Description

CJC-1295 + Ipamorelin Blend combines two extensively studied research peptides that influence complementary signaling pathways involved in growth hormone regulation. CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) engineered to exhibit prolonged biological stability, while Ipamorelin is a selective ghrelin receptor agonist recognized for its receptor specificity within experimental endocrine models.

The combination has become a widely referenced research tool because it enables scientists to investigate simultaneous activation of GHRH and ghrelin receptor pathways. Rather than examining each signaling mechanism independently, researchers can evaluate receptor cross-talk, coordinated intracellular signaling, endocrine regulation, and downstream molecular responses within controlled laboratory environments.

At Appex Peptide Lab, every batch of CJC-1295 + Ipamorelin Blend is synthesized using stringent manufacturing standards and undergoes comprehensive analytical verification to ensure purity, identity, and reproducibility. The stable lyophilized formulation supports long-term laboratory storage and consistent experimental performance across multiple research applications.

Universities, biotechnology companies, pharmaceutical organizations, and life science laboratories throughout the United States, Canada, and Australia rely on this research-grade peptide blend for advanced studies involving peptide pharmacology, receptor biology, endocrine physiology, and growth hormone signaling networks.

Key Research Highlights

  • Premium research-grade peptide blend
  • Combines CJC-1295 DAC and Ipamorelin
  • High-purity lyophilized formulation
  • Third-party laboratory tested
  • HPLC purity verification
  • Certificate of Analysis (COA) available
  • Batch-tested for consistency
  • Suitable for GHRH and ghrelin receptor research
  • Designed for endocrine signaling investigations
  • Stable formulation for laboratory applications
  • Secure packaging for research environments
  • Fast shipping to the USA, Canada, and Australia

Why Researchers Choose This Product

Researchers investigating endocrine signaling require peptide preparations with exceptional analytical quality and reproducible performance.

Researchers choose this blend because it offers:

  • High analytical purity
  • Verified identity of both peptide components
  • Excellent batch-to-batch consistency
  • Independent third-party laboratory testing
  • Stable lyophilized formulation
  • Comprehensive analytical documentation
  • Reliable peptide ratio verification
  • Research-grade manufacturing standards
  • Trusted by endocrinology and physiology laboratories
  • Optimized for advanced receptor signaling studies

Research Applications

Growth Hormone-Releasing Hormone Research

Studies investigating GHRH receptor activation, ligand binding, and intracellular signaling associated with pituitary endocrine function.

Ghrelin Receptor Biology

Experimental investigations involving selective activation of the growth hormone secretagogue receptor (GHSR-1a), receptor pharmacology, and signal transduction.

Neuroendocrine Signaling

Research examining communication between hypothalamic and pituitary signaling pathways and peptide-mediated endocrine regulation.

IGF-1 Regulatory Pathways

Laboratory studies exploring downstream molecular pathways associated with growth hormone signaling and insulin-like growth factor regulation.

Peptide Pharmacology

Research involving receptor affinity, ligand specificity, peptide stability, and structure-activity relationships.

Molecular Endocrinology

Experimental investigations evaluating intracellular signaling cascades, transcriptional responses, and endocrine communication networks.

Cell-Based Assays

Suitable for in vitro receptor activation studies, peptide characterization, and downstream signaling analysis.

Peptide Combination Research

Laboratory investigations assessing coordinated peptide activity, receptor cross-talk, and synergistic signaling mechanisms.

Product Specifications

Specification Details
Product Name CJC-1295 + Ipamorelin Blend
Available Strength 10 mg Blend
Composition CJC-1295 DAC + Ipamorelin
Purity ≥98% each peptide (HPLC Verified)
Peptide Type Synthetic GHRH Analog + Selective Ghrelin Receptor Agonist
Molecular Formula Blend of two synthetic peptides
Molecular Weight CJC-1295 DAC: ~3,649 Da; Ipamorelin: ~711.9 Da
CAS Number CJC-1295: 863288-34-0; Ipamorelin: 170851-70-4
Appearance White to off-white lyophilized powder
Solubility Soluble in appropriate laboratory-grade aqueous research solvents
Storage Conditions Store unopened at -20°C. Protect from moisture, direct light, excessive heat, and repeated freeze-thaw cycles.
Sequence CJC-1295 DAC: Modified 29-amino-acid GHRH analog with maleimidopropionyl group. Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂

CJC-1295-+-Ipamorelin-Blend-for-sale

Mechanism of Action

Within laboratory research, CJC-1295 + Ipamorelin Blend is investigated for its coordinated activation of two distinct endocrine signaling pathways that regulate growth hormone physiology. Each peptide interacts with a different receptor system, allowing researchers to study complementary molecular mechanisms within a single experimental model.

CJC-1295 functions as a synthetic analog of growth hormone-releasing hormone (GHRH) and binds to the growth hormone-releasing hormone receptor (GHRHR) located on pituitary somatotroph cells. Activation of this receptor stimulates adenylate cyclase, elevates intracellular cyclic adenosine monophosphate (cAMP), activates protein kinase A (PKA), and initiates downstream transcriptional signaling associated with endocrine regulation. The addition of a Drug Affinity Complex (DAC) enables reversible albumin binding, increasing molecular stability and prolonging receptor interaction in laboratory systems.

Ipamorelin selectively targets the growth hormone secretagogue receptor (GHSR-1a), a G protein-coupled receptor activated through ghrelin-mediated signaling. Experimental studies investigate how receptor activation influences phospholipase C (PLC), intracellular calcium mobilization, protein kinase C (PKC), and mitogen-activated protein kinase (MAPK) signaling pathways. Because Ipamorelin demonstrates high receptor selectivity in laboratory models, it is frequently used to examine ghrelin receptor pharmacology and intracellular signaling dynamics.

When studied together, the blend enables researchers to evaluate receptor cross-talk between GHRHR and GHSR-1a, coordinated intracellular signaling, endocrine network regulation, and downstream pathways associated with growth hormone and insulin-like growth factor (IGF-1) signaling. Scientific investigations also explore peptide synergy, receptor sensitivity, transcriptional responses, and peptide pharmacodynamics within controlled experimental environments.

The complementary pharmacological characteristics of both peptides make this blend a valuable research tool for molecular endocrinology, receptor biology, peptide chemistry, and cellular signaling investigations. All studies involving this product are intended exclusively for laboratory research.

For research use only. Not intended for human consumption or clinical use.

Additional information

Size

10mg

Weight

.125 lbs

Dimensions

9 × 7 × .5 in

Reviews

There are no reviews yet.

Be the first to review “Buy CJC-1295 + Ipamorelin Blend | High-Purity”

Your email address will not be published. Required fields are marked *

Buy CJC-1295 + Ipamorelin Blend | High-Purity

🧬
Research Grade

Premium Laboratory Quality

📄
COA Included

Batch-Specific Documentation

🧪
Third-Party Tested

Identity & Purity Verified

🚚
Fast Shipping

Worldwide Delivery

This product is currently out of stock and unavailable.

📦
Discreet Packaging 100% Private
🛡️
Secure Shipping Fast & Reliable
Free Delivery On Crypto Payments
🚚
Expedited Shipping Delivery in 2–3 Days

Description

CJC-1295 + Ipamorelin Blend combines two extensively studied research peptides that influence complementary signaling pathways involved in growth hormone regulation. CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) engineered to exhibit prolonged biological stability, while Ipamorelin is a selective ghrelin receptor agonist recognized for its receptor specificity within experimental endocrine models.

The combination has become a widely referenced research tool because it enables scientists to investigate simultaneous activation of GHRH and ghrelin receptor pathways. Rather than examining each signaling mechanism independently, researchers can evaluate receptor cross-talk, coordinated intracellular signaling, endocrine regulation, and downstream molecular responses within controlled laboratory environments.

At Appex Peptide Lab, every batch of CJC-1295 + Ipamorelin Blend is synthesized using stringent manufacturing standards and undergoes comprehensive analytical verification to ensure purity, identity, and reproducibility. The stable lyophilized formulation supports long-term laboratory storage and consistent experimental performance across multiple research applications.

Universities, biotechnology companies, pharmaceutical organizations, and life science laboratories throughout the United States, Canada, and Australia rely on this research-grade peptide blend for advanced studies involving peptide pharmacology, receptor biology, endocrine physiology, and growth hormone signaling networks.

Key Research Highlights

  • Premium research-grade peptide blend
  • Combines CJC-1295 DAC and Ipamorelin
  • High-purity lyophilized formulation
  • Third-party laboratory tested
  • HPLC purity verification
  • Certificate of Analysis (COA) available
  • Batch-tested for consistency
  • Suitable for GHRH and ghrelin receptor research
  • Designed for endocrine signaling investigations
  • Stable formulation for laboratory applications
  • Secure packaging for research environments
  • Fast shipping to the USA, Canada, and Australia

Why Researchers Choose This Product

Researchers investigating endocrine signaling require peptide preparations with exceptional analytical quality and reproducible performance.

Researchers choose this blend because it offers:

  • High analytical purity
  • Verified identity of both peptide components
  • Excellent batch-to-batch consistency
  • Independent third-party laboratory testing
  • Stable lyophilized formulation
  • Comprehensive analytical documentation
  • Reliable peptide ratio verification
  • Research-grade manufacturing standards
  • Trusted by endocrinology and physiology laboratories
  • Optimized for advanced receptor signaling studies

Research Applications

Growth Hormone-Releasing Hormone Research

Studies investigating GHRH receptor activation, ligand binding, and intracellular signaling associated with pituitary endocrine function.

Ghrelin Receptor Biology

Experimental investigations involving selective activation of the growth hormone secretagogue receptor (GHSR-1a), receptor pharmacology, and signal transduction.

Neuroendocrine Signaling

Research examining communication between hypothalamic and pituitary signaling pathways and peptide-mediated endocrine regulation.

IGF-1 Regulatory Pathways

Laboratory studies exploring downstream molecular pathways associated with growth hormone signaling and insulin-like growth factor regulation.

Peptide Pharmacology

Research involving receptor affinity, ligand specificity, peptide stability, and structure-activity relationships.

Molecular Endocrinology

Experimental investigations evaluating intracellular signaling cascades, transcriptional responses, and endocrine communication networks.

Cell-Based Assays

Suitable for in vitro receptor activation studies, peptide characterization, and downstream signaling analysis.

Peptide Combination Research

Laboratory investigations assessing coordinated peptide activity, receptor cross-talk, and synergistic signaling mechanisms.

Product Specifications

Specification Details
Product Name CJC-1295 + Ipamorelin Blend
Available Strength 10 mg Blend
Composition CJC-1295 DAC + Ipamorelin
Purity ≥98% each peptide (HPLC Verified)
Peptide Type Synthetic GHRH Analog + Selective Ghrelin Receptor Agonist
Molecular Formula Blend of two synthetic peptides
Molecular Weight CJC-1295 DAC: ~3,649 Da; Ipamorelin: ~711.9 Da
CAS Number CJC-1295: 863288-34-0; Ipamorelin: 170851-70-4
Appearance White to off-white lyophilized powder
Solubility Soluble in appropriate laboratory-grade aqueous research solvents
Storage Conditions Store unopened at -20°C. Protect from moisture, direct light, excessive heat, and repeated freeze-thaw cycles.
Sequence CJC-1295 DAC: Modified 29-amino-acid GHRH analog with maleimidopropionyl group. Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂

CJC-1295-+-Ipamorelin-Blend-for-sale

Mechanism of Action

Within laboratory research, CJC-1295 + Ipamorelin Blend is investigated for its coordinated activation of two distinct endocrine signaling pathways that regulate growth hormone physiology. Each peptide interacts with a different receptor system, allowing researchers to study complementary molecular mechanisms within a single experimental model.

CJC-1295 functions as a synthetic analog of growth hormone-releasing hormone (GHRH) and binds to the growth hormone-releasing hormone receptor (GHRHR) located on pituitary somatotroph cells. Activation of this receptor stimulates adenylate cyclase, elevates intracellular cyclic adenosine monophosphate (cAMP), activates protein kinase A (PKA), and initiates downstream transcriptional signaling associated with endocrine regulation. The addition of a Drug Affinity Complex (DAC) enables reversible albumin binding, increasing molecular stability and prolonging receptor interaction in laboratory systems.

Ipamorelin selectively targets the growth hormone secretagogue receptor (GHSR-1a), a G protein-coupled receptor activated through ghrelin-mediated signaling. Experimental studies investigate how receptor activation influences phospholipase C (PLC), intracellular calcium mobilization, protein kinase C (PKC), and mitogen-activated protein kinase (MAPK) signaling pathways. Because Ipamorelin demonstrates high receptor selectivity in laboratory models, it is frequently used to examine ghrelin receptor pharmacology and intracellular signaling dynamics.

When studied together, the blend enables researchers to evaluate receptor cross-talk between GHRHR and GHSR-1a, coordinated intracellular signaling, endocrine network regulation, and downstream pathways associated with growth hormone and insulin-like growth factor (IGF-1) signaling. Scientific investigations also explore peptide synergy, receptor sensitivity, transcriptional responses, and peptide pharmacodynamics within controlled experimental environments.

The complementary pharmacological characteristics of both peptides make this blend a valuable research tool for molecular endocrinology, receptor biology, peptide chemistry, and cellular signaling investigations. All studies involving this product are intended exclusively for laboratory research.

For research use only. Not intended for human consumption or clinical use.

Additional information

Size

10mg

Weight

.125 lbs

Dimensions

9 × 7 × .5 in

Reviews

There are no reviews yet.

Be the first to review “Buy CJC-1295 + Ipamorelin Blend | High-Purity”

Your email address will not be published. Required fields are marked *

MORE PRODUCTS

Bulk Orders. Better Value.

Research institutions, universities and clinical teams qualify for volume discounts. Contact our team to discuss custom formulations and bulk pricing.